P.3.040 Contribution of high-affinity binding at calcium channel α2-δ proteins to the pharmacology of pregabalin von Donevan, S., Taylor, C.P., Offord, J., Su, T.Z., Baron, S., Kinsora, J., Vartanian, M.G., Bian, F., Li, Z., Dooley, D., Wustrow, D.j., Belliotti, T., Schwarz, J., Thorpe, A.

Volltext

P.3.040 Contribution of high-affinity binding at calcium channel α 2-δ proteins to the pharmacology of pregabalin von Donevan, S., Taylor, C.P., Offord, J., Su, T.Z., Baron, S., Kinsora, J., Vartanian, M.G., Bian, F., Li, Z., Dooley, D., Wustrow, D.j., Belliotti, T., Schwarz, J., Thorpe, A.

Volltext

PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects von CORBIN, A. E, MELTZER, L. T, NINTEMAN, F. W, WILEY, J. N, CHRISTOFFERSEN, C. L, WUSTROW, D. J, WISE, L. D, PUGSLEY, T. A, HEFFNER, T. G

Volltext

Reduced amide bond neurotensin 8–13 mimetics with potent in vivo activity von Wustrow, D.J., Davis, M.D., Akunne, H.C., Corbin, A.E., Wiley, J.N., Wise, L.D., Heffner, T.G.

Volltext

PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT 1A agonist actions. II. Preclinical behavioral effects von Corbin, A.E, Meltzer, L.T, Ninteman, F.W, Wiley, J.N, Christoffersen, C.L, Wustrow, D.J, Wise, L.D, Pugsley, T.A, Heffner, T.G

Volltext

PD 158771, a potential antipsychotic agent with D 2/D 3 partial agonist and 5-HT 1A agonist actions. I. Neurochemical effects von Akunne, H.C, Zoski, K.T, Davis, M.D, Cooke, L.W, Meltzer, L.T, Whetzel, S.Z, Shih, Y.H, Wustrow, D.J, Wise, L.D, MacKenzie, R.G, Georgic, L.M, Heffner, T.G, Pugsley, T.A

Volltext

PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects von AKUNNE, H. C, ZOSKI, K. T, GEORGIC, L. M, HEFFNER, T. G, PUGSLEY, T. A, DAVIS, M. D, COOKE, L. W, MELTZER, L. T, WHETZEL, S. Z, SHIH, Y. H, WUSTROW, D. J, WISE, L. D, MACKENZIE, R. G

Volltext

Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists von Pugsley, T.A., Akunne, H.C., Whetzel, S.Z., Demattos, S., Corbin, A.E., Wiley, J.N., Wustrow, D.J., Wise, L.D., Heffner, T.G.

Volltext

Novel small molecule neurotensin antagonists: 3-(1,5-diaryl-1,5-dioxopentan-3-yl)benzoic acids von Johnson, S.J., Akunne, H.C., Heffner, T.G., Kesten, S.R., Pugsley, T.A., Wise, L.D., Wustrow, D.J.

Volltext

Benzoxazinone dopamine D4 receptor antagonists von L.D. WISE, D.J. WUSTROW, T. BELLIOTTI

Volltext bestellen

Preliminary evaluation of isocyanate-generating nitroheterocycles as chemosensitizers, radiosensitizers and hypoxic cell cytotoxic agents von Mulcahy, R.Timothy, Wustrow, David J, Kende, Andrew S

Volltext

MONO-AND DISUBSTITUTED 3-PROPYL GAMMA-AMINOBUTYRIC ACIDS von L.D. WISE, D.J. WUSTROW, I.V. EKHATO, T.R. BELLIONTTI, J.B. SCHWARZ, A.J. THORPE, PO-WAI YUEN, R.M. SCHELKUN, J.S. BRYANS, A.T. OSUMA

Volltext bestellen

BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY von S.M. HUTSON, D.J. WUSTROW, M.F. RAFFERTY, T-Z. SU, L-Y. HU, T.R. RYDER, D.F. WELTY, E. LIETH, K.F. LANOUE, J.S. BRYANS

Volltext bestellen

555 CB-5083, a first in class inhibitor of the AAA-ATPase p97/VCP, induces irresolvable ER stress that results in antitumor activity in solid and hematological tumor models von Yakes, F, Le Moigne, R, Wong, S, Anderson, D.J, Djakovic, S, Valle, E, Menon, M.K, Rice, J, Yao, B, Soriano, F, Wang, J, von Soly, S. Kiss, Chesi, M, Bergsagel, P.L, Zhou, H.J, Rolfe, M, Wustrow, D

Volltext